Témata prací (Výběr práce)Témata prací (Výběr práce)(verze: 379)
Detail práce
   Přihlásit přes CAS
Imunohistochemická analýza exprese endoglinu a biomarkerů zánětu během jaterní fibrózy po podávání Carotuximabu
Název práce v češtině: Imunohistochemická analýza exprese endoglinu a biomarkerů zánětu během jaterní fibrózy po podávání Carotuximabu
Název v anglickém jazyce: Immunohistochemical analysis of endoglin expression and biomarkers of inflammation during liver fibrosis after Carotuximab administration
Akademický rok vypsání: 2021/2022
Typ práce: rigorózní práce
Jazyk práce: čeština
Ústav: Katedra biologických a lékařských věd (16-16150)
Vedoucí / školitel: prof. PharmDr. Petr Nachtigal, Ph.D.
Řešitel: skrytý - zadáno a potvrzeno stud. odd.
Datum přihlášení: 19.07.2022
Datum zadání: 19.07.2022
Datum potvrzení stud. oddělením: 19.07.2022
Datum a čas obhajoby: 13.03.2023 00:00
Datum odevzdání elektronické podoby:01.03.2023
Datum proběhlé obhajoby: 13.03.2023
Oponenti: PharmDr. Barbora Vitverová, Ph.D.
 
 
 
Zásady pro vypracování
Literární rešerše
Western blot analýza vybraných proteinů
Sepsání diplomové práce
Seznam odborné literatury
1. Oujo B, Perez-Barriocanal F, Bernabeu C, Lopez-Novoa JM (2013) Membrane and soluble forms of endoglin in preeclampsia. Curr Mol Med 13 (8):1345-1357
2. Bot PT, Hoefer IE, Sluijter JP, van Vliet P, Smits AM, Lebrin F, Moll F, de Vries JP, Doevendans P, Piek JJ, Pasterkamp G, Goumans MJ (2009) Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques. Stroke 40 (2):439-447. doi:STROKEAHA.108.522284 [pii]
10.1161/STROKEAHA.108.522284
3. St-Jacques S, Forte M, Lye SJ, Letarte M (1994) Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 51 (3):405-413
4. Meurer S, Wimmer AE, Leur EV, Weiskirchen R (2019) Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on N-Glycosylation. Cells 8 (9). doi:10.3390/cells8090997
5. Lastres P, Bellon T, Cabanas C, Sanchez-Madrid F, Acevedo A, Gougos A, Letarte M, Bernabeu C (1992) Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol 22 (2):393-397
6. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al. (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8 (4):345-351. doi:10.1038/ng1294-345
7. Kapur NK, Morine KJ, Letarte M (2013) Endoglin: a critical mediator of cardiovascular health. Vasc Health Risk Manag 9:195-206. doi:10.2147/VHRM.S29144
8. Qu R, Silver MM, Letarte M (1998) Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation. Cell Tissue Res 292 (2):333-343
9. Alsamman M, Sterzer V, Meurer SK, Sahin H, Schaeper U, Kuscuoglu D, Strnad P, Weiskirchen R, Trautwein C, Scholten D (2018) Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosis. Liver Int 38 (5):858-867. doi:10.1111/liv.13595
10. Vicen M, Vitverova B, Havelek R, Blazickova K, Machacek M, Rathouska J, Najmanova I, Dolezelova E, Prasnicka A, Sternak M, Bernabeu C, Nachtigal P (2019) Regulation and role of endoglin in cholesterol-induced endothelial and vascular dysfunction in vivo and in vitro. FASEB J 33 (5):6099-6114. doi:10.1096/fj.201802245R
11. Rossi E, Sanz-Rodriguez F, Eleno N, Duwell A, Blanco FJ, Langa C, Botella LM, Cabanas C, Lopez-Novoa JM, Bernabeu C (2013) Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood 121 (2):403-415. doi:10.1182/blood-2012-06-435347
blood-2012-06-435347 [pii]
12. Aristorena M, Gallardo-Vara E, Vicen M, de Las Casas-Engel M, Ojeda-Fernandez L, Nieto C, Blanco FJ, Valbuena-Diez AC, Botella LM, Nachtigal P, Corbi AL, Colmenares M, Bernabeu C (2019) MMP-12, Secreted by Pro-Inflammatory Macrophages, Targets Endoglin in Human Macrophages and Endothelial Cells. Int J Mol Sci 20 (12). doi:10.3390/ijms20123107
13. Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, Sier CF, ten Dijke P (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70 (10):4141-4150. doi:0008-5472.CAN-09-4466 [pii]
10.1158/0008-5472.CAN-09-4466
14. Valbuena-Diez AC, Blanco FJ, Oujo B, Langa C, Gonzalez-Nunez M, Llano E, Pendas AM, Diaz M, Castrillo A, Lopez-Novoa JM, Bernabeu C (2012) Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation 126 (22):2612-2624. doi:10.1161/CIRCULATIONAHA.112.101261
15. Blaha M, Cermanova M, Blaha V, Jarolim P, Andrys C, Blazek M, Maly J, Smolej L, Zajic J, Masin V, Zimova R, Rehacek V (2008) Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia. Atherosclerosis 197 (1):264-270. doi:S0021-9150(07)00261-4 [pii]
10.1016/j.atherosclerosis.2007.04.022
16. Blann AD, Wang JM, Wilson PB, Kumar S (1996) Serum levels of the TGF-beta receptor are increased in atherosclerosis. Atherosclerosis 120 (1-2):221-226
17. Malhotra R, Paskin-Flerlage S, Zamanian RT, Zimmerman P, Schmidt JW, Deng DY, Southwood M, Spencer R, Lai CS, Parker W, Channick RN, Morrell NW, Elliott CG, Yu PB (2013) Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension. Pulm Circ 3 (2):369-380. doi:10.4103/2045-8932.110445
18. Leanos-Miranda A, Navarro-Romero CS, Sillas-Pardo LJ, Ramirez-Valenzuela KL, Isordia-Salas I, Jimenez-Trejo LM (2019) Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes. Hypertension 74 (4):991-997. doi:10.1161/HYPERTENSIONAHA.119.13348
19. Doghish AS, Bassyouni AA, Mahfouz MH, Abd El-Aziz HG, Zakaria RY (2019) Plasma endoglin in Type2 diabetic patients with nephropathy. Diabetes Metab Syndr 13 (1):764-768. doi:10.1016/j.dsx.2018.11.058
20. Rathouska J, Nemeckova I, Zemankova L, Strasky Z, Jezkova K, Varejckova M, Nachtigal P (2015) Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis. Heart Vessels 30 (2):241-248. doi:10.1007/s00380-014-0493-8
21. Nachtigal P, Zemankova Vecerova L, Rathouska J, Strasky Z (2012) The role of endoglin in atherosclerosis. Atherosclerosis 224 (1):4-11. doi:10.1016/j.atherosclerosis.2012.03.001
22. Schoonderwoerd MJA, Goumans MTH, Hawinkels L (2020) Endoglin: Beyond the Endothelium. Biomolecules 10 (2). doi:10.3390/biom10020289
23. Xu G, Barrios-Rodiles M, Jerkic M, Turinsky AL, Nadon R, Vera S, Voulgaraki D, Wrana JL, Toporsian M, Letarte M (2014) Novel protein interactions with endoglin and activin receptor-like kinase 1: potential role in vascular networks. Molecular & cellular proteomics : MCP 13 (2):489-502. doi:10.1074/mcp.M113.033464
24. Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265 (15):8361-8364
25. Llorca O, Trujillo A, Blanco FJ, Bernabeu C (2007) Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J Mol Biol 365 (3):694-705
26. Velasco S, Alvarez-Munoz P, Pericacho M, Dijke PT, Bernabeu C, Lopez-Novoa JM, Rodriguez-Barbero A (2008) L- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J Cell Sci 121 (Pt 6):913-919. doi:jcs.023283 [pii]
10.1242/jcs.023283
27. Blanco FJ, Grande MT, Langa C, Oujo B, Velasco S, Rodriguez-Barbero A, Perez-Gomez E, Quintanilla M, Lopez-Novoa JM, Bernabeu C (2008) S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology. Circ Res 103 (12):1383-1392. doi:CIRCRESAHA.108.176552 [pii]
10.1161/CIRCRESAHA.108.176552
28. Conley BA, Smith JD, Guerrero-Esteo M, Bernabeu C, Vary CP (2000) Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis 153 (2):323-335. doi:S0021915000004226 [pii]
29. Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109 (23 Suppl 1):III27-32
 
Univerzita Karlova | Informační systém UK